Belgium · How much has Santero Therapeutics raised?
Santero Therapeutics has raised $8.6M across 1 round since 2023.
Belgium · Series A startup
Who invested in Santero Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Santero Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$8.6Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $8.6MJun 2023
- Investors
- 0
The rounds
- Jun 2023Series A$8.6M
No investor was named in the report.
Source recorded
Founders and team
From Santero Therapeutics's own website: 1 founder, 6 on the team.
- Mark BeardsChief Executive Officer
- Cuong VuongChief Scientific Officer
- Valérie GallienChief of Staff
- Albert PalomerIndependant Director
- François FontaineBoard of Directors
- Gokhan BaturChairman of the Board of Directors - Independant
AdvisersWallonie Entreprendre
Quick answers about Santero Therapeutics
When did Santero Therapeutics last raise?
Santero Therapeutics's most recent round was a Series A of $8.6M in Jun 2023.
What was Santero Therapeutics's biggest round?
Its most recent round, $8.6M in Jun 2023, is also its largest on record.
What stage is Santero Therapeutics at?
Santero Therapeutics's latest named round is a Series A, in Jun 2023.
Where is Santero Therapeutics based?
Santero Therapeutics is based in Belgium.
Companies like Santero Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.